Intervention Review

Creatine for amyotrophic lateral sclerosis/motor neuron disease

  1. Daniel M Pastula1,*,
  2. Dan H Moore2,
  3. Richard S Bedlack3

Editorial Group: Cochrane Neuromuscular Disease Group

Published Online: 12 DEC 2012

Assessed as up-to-date: 16 JUL 2012

DOI: 10.1002/14651858.CD005225.pub3

How to Cite

Pastula DM, Moore DH, Bedlack RS. Creatine for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD005225. DOI: 10.1002/14651858.CD005225.pub3.

Author Information

  1. 1

    UCSF Medical Center, Neurology, San Francisco, California, USA

  2. 2

    California Pacific Medical Center, Research Institute, San Francisco, CA, USA

  3. 3

    Duke Medical Center, Division of Neurology, Durham, USA

*Daniel M Pastula, Neurology, UCSF Medical Center, UCSF Neurology, Box 0114, 505 Parnassus Ave, San Francisco, California, 94143-0114, USA.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 12 DEC 2012


Cited in:


This article has been cited by:

  1. 1
    Hayley Dickinson, Emily Bain, Dominic Wilkinson, Philippa Middleton, Caroline A Crowther, David W Walker, Creatine for women in pregnancy for neuroprotection of the fetus, The Cochrane Library,